Stay updated on Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T20:32:04.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record. The change likely reflects new information or data related to the completed study of Single Agent Pembrolizumab versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer.
    Difference
    0.2%
    Check dated 2024-06-06T14:19:41.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying requirements such as centrally confirmed Stage IV/M1 mTNBC, a newly obtained tumor biopsy from a metastatic site, and central determination of PD-L1 tumor status. Previously, this section only indicated that no information was provided.
    Difference
    21%
    Check dated 2024-05-22T20:26:23.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:14:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.